Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001719138 | SCV000732063 | likely benign | not provided | 2018-09-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001433991 | SCV001636789 | likely benign | Developmental and epileptic encephalopathy 94 | 2024-05-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002331092 | SCV002637156 | likely benign | Inborn genetic diseases | 2017-09-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004533266 | SCV004742368 | likely benign | CHD2-related disorder | 2019-09-23 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |